| 0 |
SWEAT GLAND EXCISION |
1 |
0.0435 |
| 1 |
APPLICATION SITE FISSURE |
2 |
0.0222 |
| 2 |
FALLOPIAN TUBE OBSTRUCTION |
1 |
0.0143 |
| 3 |
DILATED PORES |
1 |
0.0110 |
| 4 |
INTRACRANIAL INFECTION |
1 |
0.0080 |
| 5 |
OVARIAN GERM CELL TERATOMA BENIGN |
1 |
0.0071 |
| 6 |
ADNEXAL TORSION |
2 |
0.0063 |
| 7 |
ADNEXA UTERI CYST |
1 |
0.0062 |
| 8 |
ACNE FULMINANS |
1 |
0.0051 |
| 9 |
CAVERNOUS SINUS THROMBOSIS |
1 |
0.0039 |
| 10 |
CENTRAL HYPOTHYROIDISM |
1 |
0.0030 |
| 11 |
CEREBRAL MASS EFFECT |
1 |
0.0028 |
| 12 |
ESSENTIAL THROMBOCYTHAEMIA |
1 |
0.0027 |
| 13 |
SUPRAPUBIC PAIN |
1 |
0.0020 |
| 14 |
ARTERITIS |
1 |
0.0016 |
| 15 |
APPLICATION SITE ULCER |
1 |
0.0014 |
| 16 |
VITAMIN B COMPLEX DEFICIENCY |
1 |
0.0013 |
| 17 |
SEPTIC EMBOLUS |
1 |
0.0012 |
| 18 |
PERIORBITAL PAIN |
1 |
0.0012 |
| 19 |
MYDRIASIS |
15 |
0.0012 |
| 20 |
SKIN HYPERPIGMENTATION |
9 |
0.0010 |
| 21 |
SKIN TEXTURE ABNORMAL |
1 |
0.0010 |
| 22 |
APPLICATION SITE EXFOLIATION |
4 |
0.0010 |
| 23 |
CONSCIOUSNESS FLUCTUATING |
1 |
0.0010 |
| 24 |
INTENTIONAL UNDERDOSE |
7 |
0.0010 |
| 25 |
OEDEMA MUCOSAL |
1 |
0.0010 |
| 26 |
OPTIC NERVE INJURY |
1 |
0.0009 |
| 27 |
PUSTULE |
2 |
0.0008 |
| 28 |
NASAL PRURITUS |
1 |
0.0008 |
| 29 |
CHEMICAL BURN OF SKIN |
2 |
0.0008 |
| 30 |
APPLICATION SITE EROSION |
1 |
0.0008 |
| 31 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 32 |
HYPOTHALAMO-PITUITARY DISORDER |
1 |
0.0007 |
| 33 |
INFECTIOUS PLEURAL EFFUSION |
1 |
0.0007 |
| 34 |
OPHTHALMOPLEGIA |
1 |
0.0006 |
| 35 |
ANTICHOLINERGIC SYNDROME |
1 |
0.0006 |
| 36 |
APPLICATION SITE BURN |
3 |
0.0006 |
| 37 |
SEBORRHOEIC DERMATITIS |
1 |
0.0006 |
| 38 |
APPLICATION SITE DRYNESS |
2 |
0.0006 |
| 39 |
PRODUCT CONTAINER ISSUE |
5 |
0.0006 |
| 40 |
SEBORRHOEA |
2 |
0.0005 |
| 41 |
CLEFT PALATE |
1 |
0.0005 |
| 42 |
APPLICATION SITE DISCOLOURATION |
2 |
0.0005 |
| 43 |
SKIN INDURATION |
1 |
0.0005 |
| 44 |
URINARY RETENTION |
16 |
0.0005 |
| 45 |
LUNG ABSCESS |
1 |
0.0005 |
| 46 |
EXOPHTHALMOS |
1 |
0.0005 |
| 47 |
APPLICATION SITE SCAB |
1 |
0.0005 |
| 48 |
DANDRUFF |
1 |
0.0005 |
| 49 |
PARESIS |
1 |
0.0004 |
| 50 |
DERMATITIS CONTACT |
5 |
0.0004 |
| 51 |
ROSACEA |
2 |
0.0004 |
| 52 |
RETINAL TEAR |
1 |
0.0004 |
| 53 |
DERMATOMYOSITIS |
1 |
0.0004 |
| 54 |
LIPOMA |
1 |
0.0004 |
| 55 |
PRODUCT ADMINISTRATION INTERRUPTED |
3 |
0.0004 |
| 56 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 57 |
PERIORBITAL SWELLING |
2 |
0.0004 |
| 58 |
SKIN WARM |
2 |
0.0003 |
| 59 |
PAIN OF SKIN |
9 |
0.0003 |
| 60 |
ACNE CYSTIC |
1 |
0.0003 |
| 61 |
SKIN IRRITATION |
13 |
0.0003 |
| 62 |
SKIN WEEPING |
1 |
0.0003 |
| 63 |
FACIAL BONES FRACTURE |
1 |
0.0003 |
| 64 |
APPLICATION SITE PAIN |
6 |
0.0003 |
| 65 |
SENSITIVE SKIN |
2 |
0.0003 |
| 66 |
SCAB |
3 |
0.0003 |
| 67 |
MICTURITION URGENCY |
3 |
0.0003 |
| 68 |
THERAPEUTIC PRODUCT INEFFECTIVE |
1 |
0.0003 |
| 69 |
VENOUS THROMBOSIS |
1 |
0.0003 |
| 70 |
POLYDIPSIA |
1 |
0.0003 |
| 71 |
ARTHRITIS BACTERIAL |
1 |
0.0002 |
| 72 |
DERMATITIS |
5 |
0.0002 |
| 73 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 74 |
SKIN BURNING SENSATION |
17 |
0.0002 |
| 75 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 76 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 77 |
APPLICATION SITE ERYTHEMA |
6 |
0.0002 |
| 78 |
ACNE |
17 |
0.0002 |
| 79 |
IRON DEFICIENCY |
1 |
0.0002 |
| 80 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 81 |
GINGIVITIS |
1 |
0.0002 |
| 82 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 83 |
SKIN EXFOLIATION |
14 |
0.0002 |
| 84 |
APPLICATION SITE IRRITATION |
2 |
0.0002 |
| 85 |
SOMNAMBULISM |
1 |
0.0002 |
| 86 |
ULCER HAEMORRHAGE |
1 |
0.0001 |
| 87 |
PANIC REACTION |
1 |
0.0001 |
| 88 |
ERYTHEMA |
28 |
0.0001 |
| 89 |
SUNBURN |
1 |
0.0001 |
| 90 |
RASH PAPULAR |
3 |
0.0001 |
| 91 |
LIVER INJURY |
3 |
0.0001 |
| 92 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 93 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
| 94 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 95 |
SKIN SWELLING |
1 |
0.0001 |
| 96 |
RASH MACULAR |
4 |
0.0001 |
| 97 |
DRY SKIN |
15 |
0.0001 |
| 98 |
LIP DRY |
1 |
0.0001 |
| 99 |
EYE INFLAMMATION |
1 |
0.0001 |
| 100 |
AFFECT LABILITY |
1 |
0.0001 |
| 101 |
SPINAL FRACTURE |
2 |
0.0001 |
| 102 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 103 |
TOOTH DISORDER |
2 |
0.0001 |
| 104 |
FISTULA |
1 |
0.0001 |
| 105 |
MADAROSIS |
1 |
0.0001 |
| 106 |
CYST |
1 |
0.0001 |
| 107 |
DERMATITIS ATOPIC |
4 |
0.0001 |
| 108 |
DYSMENORRHOEA |
1 |
0.0001 |
| 109 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 110 |
VISION BLURRED |
10 |
0.0001 |
| 111 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 112 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 113 |
DYSSTASIA |
2 |
0.0001 |
| 114 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 115 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 116 |
SCAR |
1 |
0.0001 |
| 117 |
INTENTIONAL PRODUCT MISUSE |
5 |
0.0001 |
| 118 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 119 |
UNDERDOSE |
4 |
0.0001 |
| 120 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 121 |
DYSURIA |
2 |
0.0001 |
| 122 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 123 |
SKIN FISSURES |
1 |
0.0001 |
| 124 |
SINUS DISORDER |
1 |
0.0001 |
| 125 |
DISCOMFORT |
3 |
0.0000 |
| 126 |
RIB FRACTURE |
1 |
0.0000 |
| 127 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 128 |
EATING DISORDER |
1 |
0.0000 |
| 129 |
SWELLING FACE |
3 |
0.0000 |
| 130 |
INTENTIONAL PRODUCT USE ISSUE |
4 |
0.0000 |
| 131 |
SNEEZING |
1 |
0.0000 |
| 132 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 133 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 134 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 135 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 136 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 137 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 138 |
DRY EYE |
2 |
0.0000 |
| 139 |
HAEMATEMESIS |
1 |
0.0000 |
| 140 |
GASTRITIS |
1 |
0.0000 |
| 141 |
DRUG INTERACTION |
6 |
0.0000 |
| 142 |
JAUNDICE |
1 |
0.0000 |
| 143 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 144 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 145 |
PRODUCT USE IN UNAPPROVED INDICATION |
9 |
0.0000 |
| 146 |
TREATMENT FAILURE |
3 |
0.0000 |
| 147 |
EYE PAIN |
2 |
0.0000 |
| 148 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 149 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 150 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 151 |
NASAL CONGESTION |
2 |
0.0000 |
| 152 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 153 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 154 |
HYPERSENSITIVITY |
6 |
0.0000 |
| 155 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 156 |
EYE DISORDER |
1 |
0.0000 |
| 157 |
VIRAL INFECTION |
1 |
0.0000 |
| 158 |
LIP SWELLING |
1 |
0.0000 |
| 159 |
FUNGAL INFECTION |
1 |
0.0000 |
| 160 |
GAIT INABILITY |
1 |
0.0000 |
| 161 |
TOXICITY TO VARIOUS AGENTS |
5 |
0.0000 |
| 162 |
GASTRIC DISORDER |
1 |
0.0000 |
| 163 |
NIGHTMARE |
1 |
0.0000 |
| 164 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 165 |
CRYING |
1 |
0.0000 |
| 166 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 167 |
EYE SWELLING |
1 |
0.0000 |
| 168 |
DISORIENTATION |
1 |
0.0000 |
| 169 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 170 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 171 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 172 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 173 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 174 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 175 |
CELLULITIS |
1 |
0.0000 |
| 176 |
THERAPY CESSATION |
1 |
0.0000 |
| 177 |
ABDOMINAL PAIN UPPER |
4 |
0.0000 |
| 178 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 179 |
OEDEMA |
1 |
0.0000 |
| 180 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 181 |
PRURITUS |
7 |
0.0000 |
| 182 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 183 |
BLISTER |
1 |
0.0000 |
| 184 |
EYE IRRITATION |
1 |
0.0000 |
| 185 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 186 |
BONE PAIN |
1 |
0.0000 |
| 187 |
PRODUCT DOSE OMISSION ISSUE |
5 |
0.0000 |
| 188 |
IRRITABILITY |
1 |
0.0000 |
| 189 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 190 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 191 |
RHINORRHOEA |
1 |
0.0000 |
| 192 |
AMNESIA |
1 |
0.0000 |
| 193 |
SOMNOLENCE |
3 |
0.0000 |
| 194 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 195 |
BURNING SENSATION |
1 |
0.0000 |
| 196 |
ANXIETY |
4 |
0.0000 |
| 197 |
OFF LABEL USE |
12 |
0.0000 |
| 198 |
EPISTAXIS |
1 |
0.0000 |
| 199 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 200 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 201 |
DRY MOUTH |
1 |
0.0000 |
| 202 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 203 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 204 |
BALANCE DISORDER |
1 |
0.0000 |
| 205 |
RASH |
5 |
0.0000 |
| 206 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 207 |
MALAISE |
5 |
0.0000 |
| 208 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 209 |
COUGH |
3 |
0.0000 |
| 210 |
MIGRAINE |
1 |
0.0000 |
| 211 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 212 |
DYSPEPSIA |
1 |
0.0000 |
| 213 |
HEADACHE |
6 |
0.0000 |
| 214 |
HAEMORRHAGE |
1 |
0.0000 |
| 215 |
FALL |
3 |
0.0000 |
| 216 |
INFLUENZA |
1 |
0.0000 |
| 217 |
WEIGHT INCREASED |
2 |
0.0000 |
| 218 |
DEPRESSION |
2 |
0.0000 |
| 219 |
BACK PAIN |
2 |
0.0000 |
| 220 |
PALPITATIONS |
1 |
0.0000 |
| 221 |
DRUG INEFFECTIVE |
11 |
0.0000 |
| 222 |
PSORIASIS |
1 |
0.0000 |
| 223 |
ARTHRALGIA |
3 |
0.0000 |
| 224 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 225 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 226 |
PAIN |
4 |
0.0000 |
| 227 |
PNEUMONIA |
2 |
0.0000 |
| 228 |
TREMOR |
1 |
0.0000 |
| 229 |
URTICARIA |
1 |
0.0000 |
| 230 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 231 |
MYALGIA |
1 |
0.0000 |
| 232 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 233 |
PYREXIA |
2 |
0.0000 |
| 234 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 235 |
COVID-19 |
1 |
0.0000 |
| 236 |
HYPERTENSION |
1 |
0.0000 |
| 237 |
OVERDOSE |
1 |
0.0000 |
| 238 |
CONSTIPATION |
1 |
0.0000 |
| 239 |
DECREASED APPETITE |
1 |
0.0000 |
| 240 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 241 |
FEELING ABNORMAL |
1 |
0.0000 |
| 242 |
DIZZINESS |
2 |
0.0000 |
| 243 |
FATIGUE |
3 |
0.0000 |
| 244 |
INSOMNIA |
1 |
0.0000 |
| 245 |
DYSPNOEA |
2 |
0.0000 |
| 246 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 247 |
ASTHENIA |
1 |
0.0000 |
| 248 |
NAUSEA |
2 |
0.0000 |
| 249 |
DEATH |
1 |
0.0000 |